Intellia Therapeutics
NTLA
NTLA
62 hedge funds and large institutions have $302M invested in Intellia Therapeutics in 2016 Q2 according to their latest regulatory filings, with 62 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
62
Holders Change
+61
Holders Change %
+6,100%
% of All Funds
1.66%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
62
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$112M |
| 2 |
O
OrbiMed
New York
|
+$56.8M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$22.7M |
| 4 |
Temasek Holdings
Singapore
|
+$16.9M |
| 5 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
+$16.3M |
Top Sellers
| 1 |
IA
IFP Advisors
Tampa,
Florida
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Wells Fargo
San Francisco,
California
| $51K | +$51K | +2,400 | New |
|
|
SO
52
STRS Ohio
Columbus,
Ohio
| $49K | +$49K | +2,300 | New |
|
|
BG
53
BlackRock Group
London,
United Kingdom
| $47K | +$47K | +2,191 | New |
|
|
PFO
54
Pathstone Family Office
Englewood,
New Jersey
| $39K | +$39K | +1,814 | New |
|
55
Legal & General Group
London,
United Kingdom
| $35K | +$35K | +1,561 | New |
|
56
UBS Group
Zurich,
Switzerland
| $21K | +$21K | +1,000 | New |
|
57
Citigroup
New York
| $15K | +$15K | +703 | New |
|
|
TRCT
58
Tower Research Capital (TRC)
New York
| $14K | +$14K | +641 | New |
|
59
Barclays
London,
United Kingdom
| $10K | +$10K | +490 | New |
|
60
BNP Paribas Financial Markets
Paris,
France
| $5.89K | +$5.89K | +276 | New |
|
61
Bank of America
Charlotte,
North Carolina
| $3K | +$3K | +132 | New |
|
62
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $2K | +$2K | +100 | New |
|
|
IA
63
IFP Advisors
Tampa,
Florida
| – | -$4K | -215 | Closed |
|